]>
IRCT20101130005280N56 IRCT 2022-07-09 Sabzevar University of Medical Sciences Evaluation of the effectiveness of amplified Brain Pert device on visual field observation Evaluation of the effectiveness of the enhanced Brain Pert device on visual field observation, detection of black and white color contrast and sharpness of the visually impaired and blind 2022-06-22 anticipated 30 Complete https://irct.ir/trial/62693 interventional Randomization: Not randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment. N/A Low vision. Intervention 1: Intervention group: First, a briefing session will be held for them and the purpose of the research and how to work with the device will be explained to him. Patients were introduced to the features of the BrainPort vision device, including turning the device on and off, field of view / zoom features, light intensity control, and inversion controls. We also showed maintenance issues such as how to replace the battery, how to take care of the device and troubleshooting solutions. The limitations of this technology were discussed, such as lack of color, lack of 3D depth perception, and that the stimulus is primarily a tactile perception. Intervention 2: Control group: At the end of the sessions, due to ethical issues, 5 sessions of treatment will be performed on the control group. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is En After finishing work, consult with colleagues and it will be published if all members
public Ebrahim Shirzad
Sabzevar University of Medical Sciences
sabzevar Iran (Islamic Republic of) 9192264462 +98 51 4401 1004 raikaravan@gmail.com Sabzevar University of Medical Sciences scientific Ebrahim Shirzad
Sabzevar Heshmatieh Hospital
Sabzevar Iran (Islamic Republic of) 9192264462 +98 903 926 4520 raikaravan@gmail.com Sabzevar University of Medical Sciences Iran (Islamic Republic of) Low vision on both sides and one side Having congenital low vision Disorders of the eyes or nerves of the visual pathway Failure to receive psychological treatment before entering the study Patient consent to participate in the research and to sign a written consent Low vision is not congenital 20 years 50 years Both Low vision is not congenital Oral lesions or cleft palate Structural and neurological disorders of the tongue smoking MR (mental retardation) Individual dissatisfaction with continuing research H54.50 Low vision, one eye, unspecified eye Treatment - Other Treatment - Other Intervention group: First, a briefing session will be held for them and the purpose of the research and how to work with the device will be explained to him. Patients were introduced to the features of the BrainPort vision device, including turning the device on and off, field of view / zoom features, light intensity control, and inversion controls. We also showed maintenance issues such as how to replace the battery, how to take care of the device and troubleshooting solutions. The limitations of this technology were discussed, such as lack of color, lack of 3D depth perception, and that the stimulus is primarily a tactile perception. Control group: At the end of the sessions, due to ethical issues, 5 sessions of treatment will be performed on the control group. Field of vision. Timepoint: Baseline- end of treatment. Method of measurement: score of the FrACT questionnaire. Sabzevar University of Medical Sciences Approved 2022-03-15 Sabzevar University of Medical Sciences Shohaday-e- Hasteei Blvd. Sabzevar Razavi Khorasan Iran (Islamic Republic of)